Diagnostic marker for interferon responsiveness in multiple sclerosis
US8021840B2 · kind B2 · utility
1Cited by
0References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2007 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Aug 5, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed is a method of determining interferon responsiveness in a patient suffering from multiple sclerosis. The method comprises determining an amount of a XAF-1 gene expression level in a blood sample, which is obtained from the patient undergoing interferon therapy. The amount of the XAF-1 gene expression level in the blood sample is then correlated with the responsiveness of the patient to the interferon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.